Found: 61
Select item for more details and to access through your institution.
KRAS , a New Target for Precision Medicine in Colorectal Cancer?
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3455, doi. 10.3390/cancers16203455
- By:
- Publication type:
- Article
Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Oxaliplatin-induced peripheral neuropathy with hepatic arterial versus intravenous infusion in metastatic colorectal cancer.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 10, p. 1, doi. 10.1007/s00520-024-08807-6
- By:
- Publication type:
- Article
Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.745146
- By:
- Publication type:
- Article
Conversion to Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma After Bidirectional Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 12, p. 3640, doi. 10.1245/s10434-017-6033-x
- By:
- Publication type:
- Article
Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study).
- Published in:
- PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291495
- By:
- Publication type:
- Article
A first-in-human phase I study of TAS0728, an oral covalent binding inhibitor of HER2, in patients with advanced solid tumors with HER2 or HER3 aberrations.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 5, p. 1324, doi. 10.1007/s10637-021-01104-7
- By:
- Publication type:
- Article
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 619, doi. 10.1007/s10637-017-0531-3
- By:
- Publication type:
- Article
Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 62, doi. 10.1007/s10637-017-0480-x
- By:
- Publication type:
- Article
Predictive factors of renal toxicities related to anti-VEGFR multikinase inhibitors in phase 1 trials.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 1, p. 79, doi. 10.1007/s10637-016-0402-3
- By:
- Publication type:
- Article
Sequence analyses of relapsed or refractory diffuse large B‐cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH‐EP1 study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 645, doi. 10.1002/ajh.26835
- By:
- Publication type:
- Article
Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B‐cell lymphoma: Results of LNH‐EP1 study.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 10, p. E376, doi. 10.1002/ajh.26280
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077472
- By:
- Publication type:
- Article
Development and Validation of a Bedside Score to Predict Early Death in Cancer of Unknown Primary Patients.
- Published in:
- PLoS ONE, 2009, v. 4, n. 8, p. 1, doi. 10.1371/journal.pone.0006483
- By:
- Publication type:
- Article
Patterns of progression in patients treated for immuno-oncology antibodies combination.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 221, doi. 10.1007/s00262-020-02647-z
- By:
- Publication type:
- Article
Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4446, doi. 10.3390/cancers15184446
- By:
- Publication type:
- Article
Predicting Immunotherapy Outcomes in Older Patients with Solid Tumors Using the LIPI Score.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5078, doi. 10.3390/cancers14205078
- By:
- Publication type:
- Article
Immunotherapy and Hepatocellular Cancer: Where Are We Now?
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184523
- By:
- Publication type:
- Article
Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 406, doi. 10.3390/cancers14020406
- By:
- Publication type:
- Article
Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3776, doi. 10.3390/cancers13153776
- By:
- Publication type:
- Article
Immunotherapy in Advanced Biliary Tract Cancers.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1569, doi. 10.3390/cancers13071569
- By:
- Publication type:
- Article
Peroxisome Proliferator-Activated Receptors in HBV-Related Infection.
- Published in:
- PPAR Research, 2009, p. 1, doi. 10.1155/2009/145124
- By:
- Publication type:
- Article
Management of biliary tract cancers in early‐onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 1886, doi. 10.1111/liv.15922
- By:
- Publication type:
- Article
Dysphonia induced by anti-angiogenic compounds.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 774, doi. 10.1007/s10637-013-0049-2
- By:
- Publication type:
- Article
Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients.
- Published in:
- 2010
- By:
- Publication type:
- Report
Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 8, p. 2643, doi. 10.1002/cam4.2797
- By:
- Publication type:
- Article
Analysis of circulating cell-free DNA identifies KRAS copy number gain and mutation as a novel prognostic marker in Pancreatic cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47489-7
- By:
- Publication type:
- Article
Clinical and molecular features of early onset pancreatic adenocarcinoma.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 11, p. 1969, doi. 10.1002/ijc.35135
- By:
- Publication type:
- Article
Molecular targeted therapy of BRAF -mutant colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919856494
- By:
- Publication type:
- Article
Molecular targeted therapy of BRAF -mutant colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919856494
- By:
- Publication type:
- Article
Development of a score that predicts survival among patients with bone metastasis revealing solid tumor.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2010, v. 56, n. 3, p. 234, doi. 10.1159/000316848
- By:
- Publication type:
- Article
Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.600886
- By:
- Publication type:
- Article
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I study of afatinib combined with nintedanib in patients with advanced solid tumours.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Clinical Relevance of Alternative Endpoints in Colorectal Cancer First-Line Therapy With Bevacizumab: A Retrospective Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266211
- By:
- Publication type:
- Article
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 Trial.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266211
- By:
- Publication type:
- Article
Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02134-4
- By:
- Publication type:
- Article
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02092-x
- By:
- Publication type:
- Article
Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study.
- Published in:
- Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01878-9
- By:
- Publication type:
- Article
Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetics of pazopanib administered in combination with bevacizumab.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 6, p. 1189, doi. 10.1007/s00280-014-2455-3
- By:
- Publication type:
- Article
Patients aged over 75 years enrolled in Phase I clinical trials: the Gustave Roussy experience.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 4, p. 875, doi. 10.1002/ijc.29849
- By:
- Publication type:
- Article
A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0154895
- By:
- Publication type:
- Article
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 6, p. 1005, doi. 10.1038/s41416-024-02796-3
- By:
- Publication type:
- Article
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 442, doi. 10.1038/s41416-023-02524-3
- By:
- Publication type:
- Article
First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy.
- Published in:
- NPJ Precision Oncology, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41698-020-00130-7
- By:
- Publication type:
- Article
Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations.
- Published in:
- Biomedicines, 2023, v. 11, n. 9, p. 2569, doi. 10.3390/biomedicines11092569
- By:
- Publication type:
- Article